Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Transbound Emerg Dis. 2018 Feb;65(1):96-104. doi: 10.1111/tbed.12618. Epub 2017 Feb 6.
Bovine tuberculosis (bTB) is highly prevalent in intensive dairy farms of the urban "milk-sheds" in Ethiopia, and vaccination could be a cost-effective disease control strategy. In the present study, the efficacy of Bacillus Calmette-Guerin (BCG) to protect against bTB was assessed in Holstein-Friesian calves in a natural transmission setting. Twenty-three 2-week-old calves were subcutaneously vaccinated with BCG Danish SSI strain 1331, and matched 26 calves were injected with placebo. Six weeks later, calves were introduced into a herd of M. bovis-infected animals (reactors) and kept in contact with them for 1 year. In vitro and in vivo immunological tests were performed to assess immune responses post-vaccination and during exposure. Successful vaccine uptake was confirmed by tuberculin skin test and IFN-γ responses in vaccinated calves. The kinetics of IFN-γ responses to early secretory antigen target 6 and culture filtrate protein 10 (ESAT6 and CFP10, respectively) and tuberculin skin test responses post-exposure suggested that the animals were infected early after being placed in contact with the infected herd as immunological signs of infection were measurable between 2 and 4 months post-initial exposure. Protection was determined by comparing gross and microscopic pathology and bacteriological burden between vaccinated and control calves. BCG vaccination reduced the proportions of tissues with visible pathology in vaccinates compared to control calves by 49% (p < .001) with 56%, 43%, 72%, and 38% reductions in the proportion of lesioned tisues in head, thoracic, abdominal lymph nodes, and lungs, respectively (p-values .029-.0001). In addition, the lesions were less severe grossly and microscopically in vaccinated calves than in non-vaccinated calves (p < .05). The reduction in the overall incidence rates of bTB was 23%, 28%, and 33% on the basis of the absence of gross pathology, M. bovis culture positivity, and histopathology, respectively, in vaccinated animals. In conclusion, BCG vaccination reduced the frequency and severity of the pathology of bTB significantly, which is likely to reduce onwards transmission of the disease.
牛型结核(bTB)在埃塞俄比亚城市“奶源地”的集约化奶牛场中高度流行,疫苗接种可能是一种具有成本效益的疾病控制策略。在本研究中,在自然传播环境中评估了卡介苗(BCG)对荷斯坦-弗里森牛犊预防 bTB 的功效。23 头 2 周龄的小牛通过皮下接种 BCG 丹麦 SSI 株 1331,26 头匹配的小牛注射安慰剂。6 周后,小牛被引入一群感染 M. bovis 的动物(反应者)中,并与它们保持接触 1 年。在接种疫苗后和暴露期间进行了体外和体内免疫测试,以评估免疫反应。成功的疫苗接种通过结核菌素皮肤试验和 IFN-γ 反应在接种疫苗的小牛中得到证实。在接触受感染牛群后 2 至 4 个月即可测量到感染的免疫迹象,表明动物在接触感染牛群后早期感染,早期分泌抗原靶 6 和培养滤液蛋白 10(ESAT6 和 CFP10)的 IFN-γ 反应的动力学以及结核菌素皮肤试验反应表明,接触受感染牛群后,动物早期感染。通过比较接种疫苗和对照小牛的大体和显微镜病理以及细菌负荷来确定保护。与对照小牛相比,BCG 疫苗接种使接种疫苗的小牛的可见病理组织比例降低了 49%(p<.001),头部、胸部、腹部淋巴结和肺部病变组织的比例分别降低了 56%、43%、72%和 38%(p 值分别为.029-.0001)。此外,与非接种疫苗的小牛相比,接种疫苗的小牛的病变在大体和显微镜下均较轻(p<.05)。基于接种动物的大体病理、牛分枝杆菌培养阳性和组织病理学的缺失,bTB 的总发病率分别降低了 23%、28%和 33%。总之,BCG 疫苗接种显著降低了 bTB 病理的频率和严重程度,这可能会降低疾病的传播。